Emergence of carbapenem non-susceptible Campylobacter coli after long-term treatment against recurrent bacteremia in a patient with X-linked agammaglobulinemia

Hideharu Hagiya, Keigo Kimura, Isao Nishi, Hisao Yoshida, Norihisa Yamamoto, Yukihiro Akeda, Kazunori Tomono

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We herein report a case of recurrent Campylobacter coli bacteremia in a 37-year-old Japanese man with X-linked agammaglobulinemia (XLA). The patient experienced seven episodes of C. coli bacteremia over one year, with an erythematous rash intermittently emerged on the lower limbs. Although hospitalization for intravenous treatment was repeatedly recommended, he obstinately declined it. Following long-term oral antibiotic treatment with tebipenem and faropenem for the persistent infection, C. coli showed elevated minimum in-hibitory concentrations to meropenem, a key drug for severe campylobacteriosis. Physicians should note that the overuse of antibiotics can lead to the emergence of carbapenem-non-susceptible Campylobacter strains.

Original languageEnglish
Pages (from-to)2077-2080
Number of pages4
JournalInternal Medicine
Volume57
Issue number14
DOIs
Publication statusPublished - Jan 1 2018
Externally publishedYes

Keywords

  • Bacteremia
  • Campylobacter coli
  • Carbapenem
  • Faropenem
  • Soft tissue infection
  • Tebipenem

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Emergence of carbapenem non-susceptible Campylobacter coli after long-term treatment against recurrent bacteremia in a patient with X-linked agammaglobulinemia'. Together they form a unique fingerprint.

  • Cite this